Chapter 1: Why Aging Matters More Than Ever
Why Aging Matters More Than Ever
In the summer of 2040, somewhere in suburban America, a seventy-year-old woman named Margaret will wake up, check her health metrics on a wrist-worn device, and decide whether to go for a morning run or spend the day in her home laboratory working on a research project she's been collaborating on with a university team three thousand miles away. She'll have lunch with her daughter—who is herself fifty-two—and discuss weekend plans for the whole extended family, which now includes grandchildren ranging from toddlers to teenagers. Margaret won't think of herself as elderly. She certainly won't look or feel the way her own grandmother looked and felt at seventy, forty years ago. And here's the remarkable thing: Margaret's scenario isn't science fiction. It's a reasonable projection based on the trajectory of developments already underway in longevity science.
This book is about making Margaret's future more likely—for everyone, not just those with access to cutting-edge biotechnology. It's about understanding why aging has become the most important scientific and social challenge of our time, and what the emerging science of longevity tells us about the possibilities ahead. But before we can appreciate where we're going, we need to understand why aging has suddenly become impossible to ignore, why the once-marginal field of longevity research has exploded into mainstream scientific urgency, and why the question of how we age is fundamentally inseparable from the question of how we live.
The Demographic Revolution That Changed Everything
Consider a number that seems almost impossible: there are now more people on Earth over the age of sixty-five than there are children under five. This milestone, reached in 2018 according to United Nations data, represents one of the most profound shifts in human history—a demographic revolution that has fundamentally altered the landscape of global health, economics, and social policy. For most of human existence, the great challenge was surviving childhood. Infectious diseases, accidents, and the perils of childbirth claimed lives at every age. Those who made it to adulthood might reach their forties or fifties if fortune smiled upon them, but old age—true old age, extending into the seventh or eighth decade—was a rare privilege reserved for a fortunate few.
That world is gone. In its place, we have entered an era of unprecedented longevity, but also unprecedented demographic complexity. The global population of people aged sixty and older is expected to double from approximately one billion in 2020 to nearly two billion by 2050. In developed nations, the proportion of the population over sixty-five has already surpassed twenty percent in many countries and continues to climb. Japan, often cited as the canary in the coal mine for demographic change, now has more than twenty-eight percent of its population over sixty-five, with projections suggesting that a child born today in Japan has a better than fifty percent chance of living to one hundred.
This demographic transformation didn't happen because of some sudden change in human biology. We've always had the potential for longer lives; we simply lacked the technological and social conditions to realize it. The dramatic increases in life expectancy over the past two centuries resulted from improvements in sanitation, nutrition, medicine, and living standards—the basic public health revolution that eliminated many of the infectious diseases that previously killed indiscriminately. But this revolution, while extraordinary, has left us facing a new challenge: not how to prevent early death, but how to manage the long, slow process of biological decline that we call aging.
The implications of this shift are staggering. For the first time in human history, the majority of people in many societies will spend more years in later life than in childhood. A girl born in the United States today can expect to live to eighty-seven on average, with a substantial probability of reaching ninety-five or beyond. This means that retirement, which was originally designed for a few years at the end of a much shorter life, must now accommodate decades of activity—or inactivity. It means that the diseases of aging—cancer, heart disease, neurodegenerative conditions like Alzheimer's and Parkinson's, diabetes, and a host of other chronic ailments—have become the dominant burden of human suffering and death. And it means that our social institutions, economic systems, and individual expectations must be fundamentally reimagined.
The Economic Calculus of Growing Old
The human cost of aging is impossible to separate from its economic dimensions, and these dimensions are becoming increasingly impossible to ignore. Age-related diseases currently account for the vast majority of healthcare expenditure in developed nations. In the United States, for example, healthcare spending for people over sixty-five is roughly three to five times higher than for those under thirty-five, and this ratio is projected to increase as the population ages. The United States spends approximately 4.3 trillion dollars annually on healthcare, with a substantial and growing fraction attributable to the chronic conditions of aging.
But these aggregate figures don't capture the full economic story. Consider the indirect costs: lost productivity when workers must leave the labor force due to chronic illness, the enormous burden on family caregivers who sacrifice their own careers and well-being to care for aging relatives, the educational and emotional costs when children must navigate their parents' cognitive decline. Alzheimer's disease alone—the sixth leading cause of death in the United States, and the only one among the top ten for which there is no meaningful treatment or cure—is estimated to cost the American economy over 300 billion dollars annually, a figure that could exceed one trillion dollars by 2050 if current trends continue.
These numbers are terrifying, but they also illuminate something crucial: aging isn't just a biological process happening to individuals. It's an economic and social system with feedbacks, incentives, and compounding effects. When we talk about the "burden" of aging, we're not just talking about suffering—we're talking about resource allocation, opportunity costs, and the sustainability of entire economic models. Social Security and Medicare in the United States, pension systems in Europe, healthcare financing in Japan—these are not abstract fiscal abstractions. They are the frameworks that determine whether societies can thrive in an aging world, or whether they will buckle under demographic weight they were never designed to bear.
The economist David Cutler has estimated that eliminating the diseases of aging entirely would increase total healthcare spending only modestly, because the money saved on acute care would be roughly offset by increased spending on other conditions. But this calculation, while interesting, misses a crucial point. The goal of longevity science is not merely to extend life—it is to compress the period of decline and disability at its end, allowing people to remain healthy, active, and productive for as long as possible. This compression of morbidity, as the epidemiologist James Fries famously called it, would transform not only individual lives but entire economic systems.
Imagine a world where the typical person remains fully functional—physically, cognitively, and economically—until age ninety or beyond, and then experiences a relatively brief period of decline before passing peacefully. Such a world would not face the same demographic crisis that seems so inevitable today. It would instead benefit from longer working lives, continued innovation, and the accumulated wisdom of experienced populations. The economic calculus of aging looks very different when you factor in possibility rather than assuming inevi